DNA Test Kits Global Market Report 2025

DNA test kits consist of materials and instructions for collecting an individual's DNA sample, typically obtained through saliva or cheek swabs. These kits facilitate genetic testing for ancestry, health traits, and disease predispositions, with samples usually sent to laboratories for analysis, yielding personalized genetic insights.

Common sample types for DNA test kits include saliva, blood, tissue, teeth and bones, and hair. Saliva, a fluid produced by salivary glands in the mouth, contains water, proteins, salts, and enzymes. These kits cater to a range of applications such as ancestry tracing, dietary analysis, and disease risk assessment, and are utilized by various entities including hospitals, diagnostic and forensic laboratories, as well as academic and research institutions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The DNA test kits market research report is one of a series of new reports from The Business Research Company that provides DNA test kits market statistics, including DNA test kits industry global market size, regional shares, competitors with a DNA test kits market share, detailed DNA test kits market segments, market trends and opportunities, and any further data you may need to thrive in the DNA test kits industry. This DNA test kits market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The dna test kits market size has grown rapidly in recent years. It will grow from $2.09 billion in 2024 to $2.49 billion in 2025 at a compound annual growth rate (CAGR) of 19.3%. The growth in the historic period can be attributed to an increase in the number of direct-to-consumer genetic tests, a rise in demand for DNA testing for health & fitness, the rise in the geriatric population, an increase in the prevalence of cancer, and rising demand for disease diagnostics.

The dna test kits market size is expected to see rapid growth in the next few years. It will grow to $4.85 billion in 2029 at a compound annual growth rate (CAGR) of 18.2%. The growth in the forecast period can be attributed to rising demand for personalized drug development, increased focus on personalized medicine, rising healthcare expenditure, increased demand for health-focused tests, focus on preventive healthcare, and increasing focus on population health management. Major trends in the forecast period include genetic testing technologies, digital health platforms, electronic medical records (EMRs), wearable devices, artificial intelligence (AI) and machine learning algorithms, drug development, ecological monitoring, biodiversity assessment, and wildlife conservation.

The forecast of 18.2% growth over the next five years reflects a modest reduction of 1.6% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper consumer access by increasing costs of direct-to-consumer genetic testing kits sourced from Iceland and Israel, thereby reducing preventive health screening adoption and elevating out-of-pocket testing expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of genetic disorders is anticipated to drive the growth of the DNA test kits market in the coming years. Genetic disorders, stemming from abnormalities in the genome, can manifest through mutations in single genes (monogenic), multiple genes (polygenic), or chromosomal anomalies. Contributing factors to this rise include heightened awareness, advancements in diagnostic methodologies, lifestyle changes, and environmental influences leading to genetic mutations. DNA test kits play a pivotal role in identifying specific gene mutations or variations associated with inherited conditions, facilitating diagnosis and personalized treatment strategies. For example, in April 2024, as reported by the Centers for Disease Control and Prevention (CDC), approximately 6,000 newborns, or one in 700 babies, are affected by Down syndrome annually. Additionally, according to the World Health Organization (WHO) in February 2023, congenital diseases account for an estimated 240,000 neonatal deaths globally within 28 days of birth each year. Hence, the escalating prevalence of genetic disorders is a key driver behind the growth of the DNA test kits market.

Prominent players in the DNA test kits market are concentrating on developing innovative offerings, such as personalized DNA kits, to gain a competitive edge. Personalized DNA kits analyze an individual's DNA to provide tailored insights into their health, ancestry, and traits. For instance, in April 2023, MapMyGenome, an India-based genomics company, introduced BeautyMap, India's inaugural DNA-based test kit offering personalized recommendations for skincare and haircare products based on an individual's genetic profile. The kit includes a complimentary genetic counseling session with a certified genetic counselor, facilitating interpretation of results and informed decision-making regarding a customized beauty regimen.

In January 2023, QIAGEN N.V., a Germany-based biotechnology company, acquired Verogen Inc. for $150 million. This acquisition enables QIAGEN to provide a comprehensive workflow in human identification and forensics, bolstering its capacity to support investigators and researchers in advancing forensic science and accurately identifying suspects. Verogen Inc., based in the United States, specializes in providing DNA test kits for forensic and human identification applications, aligning with QIAGEN's strategic objectives to expand its portfolio and capabilities in key segments of genetic testing.

Major companies operating in the DNA test kits market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, GE HealthCare Technologies Inc., Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., NeoGenomics Laboratories Inc., Ancestry.com LLC, 23andMe Holding Co, Ambry Genetics Corporation, MyHeritage Ltd., CENTOGENE N.V., Everlywell Inc., Gene by Gene Ltd., Zymo Research Corporation, Devyser, Living DNA Ltd, Veritas Genetics, Nebula Genomics

North America was the largest region in the DNA test kits market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the DNA test kits market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the DNA test kits market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The DNA test kits market consists of sales of DNA collection swabs, saliva collection tubes, transport tubes or containers, DNA sequencers, and DNA extraction and purification kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

DNA Test Kits Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on dna test kits market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for dna test kits ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The dna test kits market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Sample Type: Saliva; Blood; Tissue; Teeth And Bone; Hairs; Other Sample Types
• 2) By Application: Ancestry Testing; Diet And Nutrition; Disease Risk Assessment; Other Applications
• 3) By End User: Hospitals; Diagnostics And Forensics Laboratories; Academic And Research Institutes; Other End Users
• Subsegments:
• 1) By Saliva: Oral Swabs (Cotton Or Synthetic); Saliva Collection Devices; Home Dna Test Kits (Saliva-Based); Genealogy Dna Tests (Saliva Sample)
• 2) By Blood: Blood Collection Tubes (Venous Or Capillary); Fingerstick Blood Collection Kits; Blood-Based Paternity Testing Kits; Ancestry And Health Genetic Test Kits (Blood-Based)
• 3) By Tissue: Biopsy Samples; Skin Or Organ Tissue; Dna Extraction From Tissue Samples (For Cancer Diagnosis ); Forensic Dna Testing (Tissue Samples)
• 4) By Teeth And Bone: Dental Dna Kits (For Forensic Analysis); Bone Marrow Samples; Dental Paternity Or Ancestry Tests; Dna Extraction From Teeth For Forensic Purposes
• 5) By Hairs: Hair Follicle Dna Testing; Hair Shaft Dna Collection (For Forensic Or Paternity Tests); Genetic Testing Using Hair Samples
• 6) By Other Sample Types: Urine; Semen; Sweat Or Skin Cells; Fecal Samples; Hairbrush Or Comb Residues; Nasal Swabs; Environmental Samples (Dust, Soil)
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Becton, Dickinson and Company; GE HealthCare Technologies Inc.; Laboratory Corporation of America Holdings (LabCorp); Quest Diagnostics Incorporated; Eurofins Scientific SE; Agilent Technologies Inc.; Illumina Inc.; PerkinElmer Inc.; Beckman Coulter Inc.; Bio-Rad Laboratories Inc.; QIAGEN N.V.; Natera Inc.; Myriad Genetics Inc.; BGI Genomics Co. Ltd.; NeoGenomics Laboratories Inc.; Ancestry.com LLC; 23andMe Holding Co; Ambry Genetics Corporation; MyHeritage Ltd.; CENTOGENE N.V.; Everlywell Inc.; Gene by Gene Ltd.; Zymo Research Corporation; Devyser; Living DNA Ltd; Veritas Genetics; Nebula Genomics
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.